*2012 Video update Coming Soon!* It will include the latest scientific info from review papers on RCTs on drugs & therapies for BPD (more recent than Wikipedia,which I plan to update after I've finished the video) You can subscribe to my YouTube to know when I've uploaded it http://www.youtube.com/user/ROMI1AAT
But here is a sneak preview while I'm finishing
Showed large, statistically significant effects in the reduction of affective instability impulsivity and interpersonal problems.ITP-BPD is a modified version of Interpersonal Psychotherapy (IPT) which is a brief and very structured manual-based therapy that addresses relationship problemsPatients are encouraged to learn interpersonal skills and adapt their behaviour to current roles and situations.
Dynamic Deconstructive Psychotherapy (DDP)
is a type of psychodynamic psychotherapy used to treat BPD and other complex behavior problems such as drug dependence,self-harm, eating disorders, recurrent suicide attempts & co-occurring disorders,such as substance use disorders or additional personality disorders.
Weekly 1-hour individual sessions over 12 to 18 months
There were no statistically significant results when compared to a therapy control.Encouraging effects on core BPD & associated pathology were found, showing that it may help severely ill patients.
Disorder-specific treatments should be used.
Nonspecific treatments that were investigated:Cognitive Behavioural Therapy (CBT), Client-Centered Therapy (CCT), Interpersonal Psychotherapy (IPT) showed no encouraging effects for the treatment of BPD core pathology. The best length of treatment is unclear Based on the available findings, a treatment of 12 to 18 months seems to be appropriate.
Yi-gan san for the treatment of borderline personality : an open-label study.
Recent studies indicate that the traditional Chinese herbal medicine yi-gan san (YGS, yokukan-san in Japanese) may be safe and useful in treating behavioral and psychological symptoms in dementia patients. We aimed at evaluating both efficacy and safety of yi-gan san in patients with well-defined BPD.
Twenty female outpatients diagnosed with BPD according to DSM-IV criteria and the revised Diagnostic Interview for Borderlinescompleted a 12-week open-label study with yi-gan san at an average daily dosage of 6.4+/-1.9 g (2.5-7.5 g). Psychometric instruments to assess efficacy included the Brief Psychiatric Rating Scale (BPRS), Hamilton Rating Scales for Depression (HAM-D), Global Assessment of Functioning (GAF), Clinical Global Impression Scale (CGI), and Aggression Questionnaire (AQ).Most psychometric scale scores exhibited a highly significant improvement (total BPRS; BPRS
somatic concern, anxiety, tension,depressive mood, hostility, suspiciousness, motor retardation, uncooperativeness,and excitement subscale; CGI; GAF; AQ) over time.
In this open-label pilot study, patients treated with YGS showed statistically significant reduction on self-rated and clinician-rated scales. The present findings suggest that yi-gan san might be effective for the treatment of a number of BPD symptoms, including low mood, impulsivity, and aggression.